 |
|
Clinical Correlations in 16 Patients With Total or Partial Laminin  2 Deficiency Characterized Using Antibodies Against 2 Fragments of the Protein
L. Morandi, MD;
C. Di Blasi, PhD;
L. Farina, MD;
L. Sorokin, PhD;
G. Uziel, MD;
G. Azan, MD;
A. Pini, MD;
A. Toscano, MD;
M. Lanfossi, PhD;
S. Galbiati;
F. Cornelio, MD;
M. Mora, PhD
Arch Neurol. 1999;56:209-215.
Background Many patients with classic congenital muscular dystrophy have been found to have partial or total deficiency of the  2 chain of laminin 2 (merosin). This deficiency has mostly been studied using only 1 antibody against a fragment of the protein.
Objectives To characterize the expression of laminin 2 in the skeletal muscle of patients with laminin 2 deficiency using antibodies against 2 different portions of the protein and to correlate the immunochemical findings with clinical phenotype.
Methods We studied 4 patients with total lack of laminin 2 and 12 with partial laminin 2 deficiency with immunohistochemical techniques and Western blot analysis. We used antibodies recognizing an 80-kd fragment toward the C-terminus and a 300-kd fragment toward the amino-terminal. Patient characteristics examined were functional compromise, magnetic resonance imaging or computed tomography of the brain, electromyography, evoked potentials, and creatine kinase levels.
Results In 4 patients, immunohistochemical analysis revealed no reactivity to either antibody; in 2 patients, the 300-kd fragment alone was partially expressed; in 2 patients, the 80-kd fragment alone was partially expressed; and in 8 patients, both fragments were partially expressed. Immunoblot analysis revealed bands of reduced intensity and normal molecular weight generally corresponding to the immunohistochemical findings. Absence of both fragments or of one with reduction of the other always produced a severe clinical phenotype, while a milder clinical phenotype was observed when both fragments were partially expressed.
Conclusions Extent of laminin 2 deficiency in most cases correlates with clinical phenotype but not with peripheral and central white matter abnormalities. Skin biopsy specimens may reveal laminin 2 deficiency in patients who have normal laminin 2 levels in muscle biopsy specimens.
From the Departments of Neuromuscular Diseases (Drs Morandi, Di Blasi, Lanfossi, Cornelio, and Mora and Ms Galbiati), Neuroradiology (Dr Farina), and Child Neurology (Dr Uziel), Istituto Nazionale Neurologico "C. Besta", Milano, Italy; the Institute for Experimental Medicine, University of Erlangen-Nürnberg, Erlangen, Germany (Dr Sorokin); Istituto "Oasi M. Santissima", Troina, Enna, Italy (Dr Azan); Servizio di Neuropsichiatria Infantile, Ospedale Santa Maria Nuova, Reggio Emilia, Italy (Dr Pini); and the Clinica Neurologica II, Università di Messina, Messina, Italy (Dr Toscano).
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(2):254-255.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination
Chun et al.
JCB 2003;163:397-408.
ABSTRACT
| FULL TEXT
The expanding phenotype of laminin {alpha}2 chain (merosin) abnormalities: case series and review
Jones et al.
J. Med. Genet. 2001;38:649-657.
ABSTRACT
| FULL TEXT
Mild muscular dystrophy due to a nonsense mutation in the LAMA2 gene resulting in exon skipping
Di Blasi et al.
Brain 2001;124:698-704.
ABSTRACT
| FULL TEXT
|
